The interplay between ACSL4, FASN, and SCD underscores a coordinated lipid metabolism axis in BQ-driven breast cancer, with ACSL4 as the key effector of energy production, potentially supporting metastatic potential by providing energy for EMT and invasion. The gene discussed is SCD; the disease is breast cancer.